Article Listing - Growth At Merck KGaA in 1995 To Continue In 1996

ARES-SERONO Rx DRUG SALES UP 15.5%

16 March 1992

On group sales of $751.1 million for the year ended December 31, 1991 (reported in brief last week), Swiss-based Ares-Serono...

MEDEVA'S ROAD TO SUCCESS

16 March 1992

Ahead of the company's 1991 financal results, which are due out next week, there has been a variety of comment...

FRENCH DOCTORS ATTACK COST DEAL

16 March 1992

The French general practitioners' union, MG-France, has warned of the effects which the health cost control deal just agreed between...

FRENCH, GERMAN, SWISS HEALTH CARE COSTS

16 March 1992

Health care spending continues to rise remorselessly in Germany and France, although control measures are having partial success.

New figures from...

PHARMA UNIT SALE LIFTS GIST-BROCADES

16 March 1992

Excluding the pharmaceuical division which it sold to Yamanouchi last year, Dutch company Gist-Brocades saw turnover for 1991 increase by...

GERMANY'S HOECHST, BAYER PROFITS DOWN

16 March 1992

German chemical/pharmaceutical groups reporting 1991 results last week, despite profit declines and dividend cuts, saw their share prices rise.

Among...

TAMOXIFEN TRIAL IN MEN

16 March 1992

- Imperial Chemical Indus-tries' Nolvadex (tamoxifen) is prolonging the lives of men with breast cancer, according to results of a...

US APPRO FOR ISIS' ANTISENSE TRIAL

16 March 1992

- Isis Pharma has received US Food and Drug Administration approval to begin human clinical trials with an anti-sense compound....

GENZYME AND GLYCOPROTEINS

16 March 1992

- Genzyme Corp, in collaboration with Robert Van Etten and colleagues at Purdue University, Indiana, has developed technol-ogy which could...

COMBO THERAPY FOR LEISHMANIASIS

16 March 1992

- The combination of allopurinol and meglumine antimoniate is more effective than the latter alone for American cutaneous leishmaniasis, according...